Restart Abilify Maintena After Two-Month Lapse
Since more than 6 weeks have elapsed since the last injection (you're at 8 weeks), you must restart the injection regimen from the beginning using either the 1-day or 14-day initiation protocol 1.
Why Complete Reinitiation is Required
The FDA-approved prescribing information is explicit: when the fourth or subsequent doses are missed and more than 6 weeks have elapsed, you cannot simply resume injections—you must restart treatment as if initiating therapy for the first time 1. At two months (8 weeks), aripiprazole plasma concentrations have fallen below therapeutic levels, and the patient has essentially lost medication coverage.
Two Reinitiation Options
You have two FDA-approved pathways to restart:
Option 1: 1-Day Initiation (Two-Injection Start)
- Administer two separate 400 mg IM injections on the same day in different injection sites (deltoid or gluteal—do NOT inject both in the same muscle)
- Plus one 20 mg oral aripiprazole dose on day 1
- No additional oral supplementation needed
- Resume monthly 400 mg injections thereafter 1
Option 2: 14-Day Initiation (Single-Injection Start)
- Administer one 400 mg IM injection (deltoid or gluteal)
- Continue oral aripiprazole 10-20 mg daily for 14 consecutive days to maintain therapeutic concentrations during reinitiation
- Resume monthly 400 mg injections thereafter 1
Practical Considerations for Choosing Between Options
The 1-day initiation (two-injection start) is increasingly preferred because it eliminates reliance on 14 days of oral adherence—precisely the issue that likely contributed to missing the injection in the first place 2, 3, 4. Pharmacokinetic modeling demonstrates the two-injection regimen achieves comparable plasma concentrations to the 14-day oral supplementation approach, with the active moiety reaching therapeutic window levels more reliably 2, 3.
Real-world survey data from European healthcare professionals shows high satisfaction with the two-injection start (84% satisfied with patient outcomes), with most finding it easy to administer (79.8%) and well-tolerated 4. The main barrier is patient reluctance to receive two injections on one day (66% of prescribers cited this) 4.
If the patient refuses two injections, use the 14-day initiation, but recognize you're betting on 14 days of oral adherence in someone who already missed an injection appointment.
Critical Safety Points
- First, confirm oral aripiprazole tolerability if this patient has never taken oral aripiprazole before. Due to the 75-94 hour half-life of aripiprazole and its active metabolite, allow up to 2 weeks to assess tolerability before initiating the LAI 1
- Check for CYP2D6 poor metabolizer status or concomitant strong CYP2D6/CYP3A4 inhibitors—these require dose adjustments (typically to 300 mg) 1
- Monitor for extrapyramidal symptoms, including rare presentations like rabbit syndrome, which has been reported even with LAI aripiprazole 5
Common Pitfall to Avoid
Do not simply give the missed 400 mg injection today and resume monthly dosing. The 6-week cutoff exists because aripiprazole concentrations decay below therapeutic levels, and resuming without reinitiation risks inadequate coverage and potential relapse. The prescribing information distinguishes between early missed doses (2nd-3rd injections: 5-week cutoff) and later missed doses (4th+ injections: 6-week cutoff) because steady-state pharmacokinetics differ 1.
After Reinitiation
Schedule the next injection 4 weeks (no sooner than 26 days) after today's reinitiation. Address barriers to adherence—consider calendar reminders, clinic appointment systems, or involving family/caregivers to prevent future lapses.